Behzad Hajari
@BehzadHajari
Followers
307
Following
3K
Media
15
Statuses
332
RT @ASHMMedia: 1/2 Recognise the achievements and uplift an emerging leader working in the #BBV, #STI, or sexual and reproductive health se….
0
5
0
RT @NDARCNEWS: Can you help us? . We are looking for data for our global #prison review examining #bloodborne virus infections, drug use an….
0
5
0
RT @INHepSU: Join #INHSUEMCR & @CHERISHresearch for a webinar with @ali_jalali_ & @ShashiKapadiaMD. Learn:. ➡️Purpose & approach to economi….
0
11
0
RT @DanielavSanten: Interested in #HCV elimination, and in particular the role of reinfection? read more about it in this paper! . Very hap….
0
2
0
RT @jasongrebely: Great to see this paper in press @LancetGastroHep Amazing leadership from Alison Marshall @KirbyInstitute to pull togethe….
0
7
0
RT @KirbyInstitute: Globally, only 49% of people who inject drugs were tested for HIV & 47% for hepatitis C. Study by @KirbyInstitute @NDAR….
0
4
0
RT @carlatreloar: Our new paper - open access! . Views of key informants on evidence and targets to achieve hepatitis C elimination goals….
0
6
0
RT @INHepSU: Join @BehzadHajari at #INHSU2023 for a presentation on "Global, regional, and country-level coverage of testing and treatment….
0
3
0
RT @KirbyInstitute: 🌟 We're proud to present our 2022 Annual Report. 🌟.In 2022, our team of passionate researchers contributed significant,….
0
6
0
Our study @KirbyInstitute @UNSWMedicine demonstrated that 9% of people with #HCV in 🇦🇺 discontinued therapy (6% in 2016 to 15% in 2021). This📈corresponds to expanding therapy to more marginalized people & highlights needs for access to adherence support & retreatment. @gregdore2.
Important: more people are stopping hepatitis C treatment early in a Nationwide study from Australia . Some will have been cured by the time they stop. Many may not. It means we need good follow-up, short-duration treatments. #livertwitter
1
5
21
RT @KirbyInstitute: Join us this coming Tuesday to hear the fascinating history of hepatitis A, B and C from Dr Michelle Bootcov @mishtory….
0
2
0
RT @Rebewinter: Latest global estimates on HIV, HCV Ab/RNA testing coverage among people who inject drugs presented by @BehzadHajari #HR….
0
3
0
RT @jasongrebely: New global data on #HCV and #HIV testing/treatment among PWID presented by @BehzadHajari @KirbyInstitute from study in co….
0
13
0
Among people who inject drugs globally, an estimated 15% are living with #HIV and 39% are living with #HCV, @jasongrebely presented in the @HRInews #HR23.@KirbyInstitute @NDARCNEWS
0
4
19
RT @INHepSU: WEBINAR: Hear from authors of top-ranked research papers from #INHSUPrisons2022 Bibliography. 📣 Speakers @jack_stone22, Timoth….
0
5
0
RT @SamanthaColled1: Proud of our team for publishing 2 systematic reviews in the Lancet Glob Health on the prevalence of injecting drug us….
0
11
0
RT @UNSWmedECAN: Are you an ECR at @UNSWMedicine? Med ECAN have limited paid spots for @StatsCentralAus short courses in 2023! Email your….
0
2
0
RT @KirbyInstitute: Applications open now for the David Cooper Scholarship!.🔬 4yr PhD for candidates in infectious diseases .📈 career devel….
0
3
0
RT @KirbyInstitute: In Australia, among 95,272 people with #hepC receiving DAA therapy by end of 2021, 7% were retreated. 52% of retreatmen….
0
2
0